Roland Selig
Vice president Medicinal Chemistry/Drug Substance at HepaRegeniX GmbH- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Deutsch Native or bilingual proficiency
-
Englisch Professional working proficiency
Topline Score
Bio
Credentials
-
The Science and Business of Biotechnology
Massachusetts Institute of TechnologyApr, 2022- Nov, 2024 -
Creating Innovative Business Models
University System of MarylandMar, 2021- Nov, 2024 -
Healthcare Finance
Massachusetts Institute of TechnologyApr, 2019- Nov, 2024 -
MBA International Extension Programme
University of MaltaNov, 2018- Nov, 2024 -
Business Model Innovation
Institut für Business Model Innovation (IfBMI)Jul, 2018- Nov, 2024
Experience
-
HepaRegeniX GmbH
-
Germany
-
Biotechnology Research
-
1 - 100 Employee
-
Vice president Medicinal Chemistry/Drug Substance
-
Jan 2022 - Present
-
-
Project Manager Drug Discovery/Senior Scientist
-
Oct 2017 - Jan 2022
-
-
-
-
Pharma Process Development
-
Apr 2017 - Oct 2017
Process development industrial scale API manufacturing Process development industrial scale API manufacturing
-
-
-
ratiopharm
-
Germany
-
Pharmaceutical Manufacturing
-
300 - 400 Employee
-
Senior R&D Manager Chemical Research
-
Jun 2011 - Apr 2017
- Leading chemical research projects - Development of project strategies to create own patent landscapes, related to API and formulation issues - Working closely with formulation experts / patent attorneys / strategic product analysts - Creating detailed project plans and controlling deliverables - Planning staff time and developing project cost estimations - Ensuring project success, on time and within budget - Supervising multi-talented lab teams throughout complex start to finish chemical research projects - Developing synthesis from bench to pilot scales - Screening for alternative API forms (salts / polymorphs and cocrystals) - Tracking and finalizing physicochemical characterizations - Monitoring third party manufacturing contracts - Providing intercompany support for multinational scientific research and development teams - Heading cross functional patent filing teams to securing expedited market introduction - Summarizing and transferring full project results ensuring technology continuity - Planning of innovative medicinal chemistry programs (drug design concepts)
-
-
-
Universität Tübingen
-
Research Services
-
200 - 300 Employee
-
PhD student
-
2006 - 2011
- Organic synthesis - Drug design - Synthesis development (to target compounds, creating versatile and efficient synthetic platforms) - SAR studies - In vitro testing - Development of high throughput and in vitro testing system, based on fluorescence polarization - Organic synthesis - Drug design - Synthesis development (to target compounds, creating versatile and efficient synthetic platforms) - SAR studies - In vitro testing - Development of high throughput and in vitro testing system, based on fluorescence polarization
-
-
Education
-
Eberhard Karls Universität Tübingen
M.Sc./Ph.D., Chemistry -
Hochschule Neu-Ulm
Master of Business Administration - MBA, General Management